Insulin-independent GABAA receptor-mediated response in the barrel cortex of mice with impaired met activity

Journal of Neuroscience

Volumn 36, Issue 13, 2016, Pages 3691-3697

  Lo, Fu Sun ^a   Erzurumlu, Reha S ^a   Powell, Elizabeth M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; GABA A receptor; Inhibition; Insulin; Met tyrosine kinase; Thalamocortical

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMPA RECEPTOR; PICROTOXIN; 2,3-DIOXO-6-NITRO-7-SULFAMOYLBENZO(F)QUINOXALINE; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR BLOCKING AGENT; ANTIDIABETIC AGENT; EMPTY SPIRACLES HOMEOBOX PROTEINS; HOMEODOMAIN PROTEIN; INSULIN; MET PROTEIN, HUMAN; QUINOXALINE DERIVATIVE; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; GENE; GENOTYPE; LONG TERM DEPRESSION; MET GENE; MOUSE; NERVE CELL DIFFERENTIATION; NEUROMODULATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOMATOSENSORY CORTEX; SPIKE; ANIMAL; BRAIN CORTEX; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; EXCITATORY POSTSYNAPTIC POTENTIAL; GENETICS; HUMAN; IN VITRO STUDY; INHIBITORY POSTSYNAPTIC POTENTIAL; METABOLISM; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; CEREBRAL CORTEX; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GABA ANTAGONISTS; GABAERGIC NEURONS; HOMEODOMAIN PROTEINS; HUMANS; HYPOGLYCEMIC AGENTS; IN VITRO TECHNIQUES; INHIBITORY POSTSYNAPTIC POTENTIALS; INSULIN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PATCH-CLAMP TECHNIQUES; PICROTOXIN; PROTO-ONCOGENE PROTEINS C-MET; QUINOXALINES; RECEPTORS, GABA-A; TRANSCRIPTION FACTORS;

EID: 84962030367     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0006-16.2016     Document Type: Article

References (48)

1. Agmon A, Connors BW (1992) Correlation between intrinsic firing patterns and thalamocortical synaptic responses of neurons in mouse barrel cortex. J Neurosci 12:319-329.Medline
2. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: American Psychiatric Association.
3. Baum SH, Stevenson RA, Wallace MT (2015) Behavioral, perceptual, and neural alterations in sensory and multisensory function in autism spectrum disorder. Prog Neurobiol 134:140-160.CrossRef Medline
4. Beierlein M, Gibson JR, Connors BW (2003) Two dynamically distinct inhibitory networks in layer 4 of the neocortex. J Neurophysiol 90:2987-3000.CrossRef Medline
5. Bissonette GB, Bae MH, Suresh T, Jaffe DE, Powell EM (2014) Prefrontal cognitive deficits in mice with altered cerebral cortical GABAergic interneurons. Behav Brain Res 259:143-151.CrossRef Medline
6. Bissonette GB, Schoenbaum G, Roesch MR, Powell EM (2015) Interneurons are necessary for coordinated activity during reversal learning in orbitofrontal cortex. Biol Psychiatry 77:454-464.CrossRef Medline
7. Blatt GJ, Fatemi SH (2011) Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications. Anat Rec 294: 1646-1652.
8. CrossRef Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, Elia M, Schneider C, Melmed R, Sacco R, Persico AM, Levitt P (2006) A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U SA 103:16834-16839.CrossRef Medline
9. Campbell DB, Warren D, Sutcliffe JS, Lee EB, Levitt P (2010) Association of MET with social and communication phenotypes in individuals with autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet 153B: 438-446.Medline
10. Cellot G, Cherubini E (2014) Reduced inhibitory gate in the barrel cortex of Neuroligin3R451C knock-in mice, an animal model of autism spectrum disorders. Physiol Rep 2:e12077.
11. Medline Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu HC, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY (2010) Dysfunction in GABA signalling mediates autismlike stereotypies and Rett syndrome phenotypes. Nature 468:263-269.CrossRef Medline
12. Duarte AI, Moreira PI, Oliveira CR (2012) Insulin in central nervous system: more than just a peripheral hormone. J Aging Res 2012:384017.Medline
13. Ebrahimi-Fakhari D, Sahin M (2015) Autism and the synapse: emerging mechanisms and mechanism-based therapies. Curr Opin Neurol 28: 91-102.CrossRef Medline
14. Enticott PG, Kennedy HA, Rinehart NJ, Tonge BJ, Bradshaw JL, Fitzgerald PB (2013) GABAergic activity in autism spectrum disorders: an investigation of cortical inhibition via transcranial magnetic stimulation. Neuropharmacology 68:202-209.CrossRef Medline
15. Feldmeyer D, Egger V, Lubke J, Sakmann B (1999) Reliable synaptic connections between pairs of excitatory layer 4 neurones within a single ‘barrel’ of developing rat somatosensory cortex. J Physiol 521:169-190.CrossRef Medline
16. Gabernet L, Jadhav SP, Feldman DE, Carandini M, Scanziani M (2005) Somatosensory integration controlled by dynamic thalamocortical feedforward inhibition. Neuron 48:315-327.CrossRef Medline
17. Gaetz W, Bloy L, Wang DJ, Port RG, Blaskey L, Levy SE, Roberts TP (2014) GABA estimation in the brains of children on the autism spectrum: measurement precision and regional cortical variation. Neuroimage 86:1-9.CrossRef Medline
18. Gatto CL, Broadie K (2010) Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Synaptic Neurosci 2:4.
19. Medline Hedrick A, Lee Y, Wallace GL, Greenstein D, Clasen L, Giedd JN, Raznahan A (2012) Autism risk geneMETvariation and cortical thickness in typically developing children and adolescents. Autism Res 5:434-439.CrossRef Medline
20. Hussman JP (2001) Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. J Autism Dev Disord 31:247-248.CrossRef Medline
21. Jackson PB, Boccuto L, Skinner C, Collins JS, Neri G, Gurrieri F, Schwartz CE (2009) Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder. Autism Res 2:232-236.CrossRef Medline
22. Jacobs KM, Kharazia VN, Prince DA (1999) Mechanisms underlying epileptogenesis in cortical malformations. Epilepsy Res 36:165-188.CrossRef Medline
23. Kovacs P, Hajnal A (2009) In vivo electrophysiological effects of insulin in the rat brain. Neuropeptides 43:283-293.CrossRef Medline
24. Lee CC, Sherman SM (2008) Synaptic properties of thalamic and intracortical inputs to layer 4 of the first-and higher-order cortical areas in the auditory and somatosensory systems. J Neurophysiol 100:317-326.CrossRef Medline
25. Lee LJ, Iwasato T, Itohara S, Erzurumlu RS (2005) Exuberant thalamocortical axon arborization in cortex-specific NMDAR1 knockout mice. J Comp Neurol 485:280-292.CrossRef Medline
26. Levitt P, Eagleson KL, Powell EM (2004) Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci 27:400-406.CrossRef Medline
27. Lo FS, Zhao S, Erzurumlu RS (2011) Astrocytes promote peripheral nerve injury-induced reactive synaptogenesis in the neonatal CNS. J Neurophysiol 106:2876-2887.CrossRef Medline
28. Martins GJ, Plachez C, Powell EM (2007) Loss of embryonic MET signaling alters profiles of hippocampal interneurons. Dev Neurosci 29:143-158.CrossRef Medline
29. Martins GJ, Shahrokh M, Powell EM (2011) Genetic disruption of Met signaling impairs GABAergic striatal development and cognition. Neuroscience 176:199-209.CrossRef Medline
30. Mielke JG, Wang YT (2005) Insulin exerts neuroprotection by counteracting the decrease in cell-surface GABA receptors following oxygen-glucose deprivation in cultured cortical neurons. J Neurochem 92:103-113.CrossRef Medline
31. Nusser Z, Cull-Candy S, Farrant M (1997) Differences in synaptic GABA(A) receptor number underlie variation in GABA mini amplitude. Neuron 19:697-709.CrossRef Medline
32. Nusser Z, Hájos N, Somogyi P, Mody I (1998) Increased number of synaptic GABA(A) receptors underlies potentiation at hippocampal inhibitory synapses. Nature 395:172-177.CrossRef Medline
33. Otis TS, De Koninck Y, Mody I (1994) Lasting potentiation of inhibition is associated with an increased number of gamma-aminobutyric acid type A receptors activated during miniature inhibitory postsynaptic currents. Proc Natl Acad Sci U S A 91:7698-7702.CrossRef Medline
34. Powell EM, Mars WM, Levitt P (2001) Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon. Neuron 30:79-89.CrossRef Medline
35. Puts NA, Wodka EL, Tommerdahl M, Mostofsky SH, Edden RA (2014) Impaired tactile processing in children with autism spectrum disorder. J Neurophysiol 111:1803-1811.CrossRef Medline
36. Rubenstein JL, Merzenich MM (2003) Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2: 255-267.CrossRef Medline
37. Rudie JD, Brown JA, Beck-Pancer D, Hernandez LM, Dennis EL, Thompson PM, Bookheimer SY, Dapretto M (2012a) Altered functional and structural brain network organization in autism. Neuroimage Clin 2:79-94.Medline
38. Rudie JD, Hernandez LM, Brown JA, Beck-Pancer D, Colich NL, Gorrindo P, Thompson PM, Geschwind DH, Bookheimer SY, Levitt P, Dapretto M (2012b) Autism-associated promoter variant in MET impacts functional and structural brain networks. Neuron 75:904-915.CrossRef Medline
39. Sahin M, Sur M. (2015) Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders. Science 350: pii: aab3897.CrossRef Medline
40. Smith JM, Xu J, Powell EM (2012) Age dependent forebrain structural changes in mice deficient in the autism associated gene Met tyrosine kinase. Neuroimage Clin 1:66-74.CrossRef Medline
41. Sousa I, Clark TG, Toma C, Kobayashi K, Choma M, Holt R, Sykes NH, Lamb JA, Bailey AJ, Battaglia A, Maestrini E, Monaco AP (2009) MET and autism susceptibility: family and case-control studies. Eur J Hum Genet 17:749-758.CrossRef Medline
42. Stern M (2011) Insulin signaling and autism. Front Endocrinol 2:54.Medline
43. Sun QQ, Huguenard JR, Prince DA (2006) Barrel cortex microcircuits: thalamocortical feedforward inhibition in spiny stellate cells is mediated by a small number of fast-spiking interneurons. J Neurosci 26:1219-1230.CrossRef Medline
44. Tavassoli T, Bellesheim K, Siper PM, Wang AT, Halpern D, Gorenstein M, Grodberg D, Kolevzon A, Buxbaum JD (2016) Measuring sensory reactivity in autism spectrum disorder: application and simplification of a clinician-administered sensory observation scale. J Autism Dev Disord 46:287-293.CrossRef Medline
45. Thanseem I, Nakamura K, Miyachi T, Toyota T, Yamada S, Tsujii M, Tsuchiya KJ, Anitha A, Iwayama Y, Yamada K, Hattori E, Matsuzaki H, Matsumoto K, Iwata Y, Suzuki K, Suda S, Kawai M, Sugihara G, Takebayashi K, Takei N, et al. (2010) Further evidence for the role of MET in autism susceptibility. Neurosci Res 68:137-141.CrossRef Medline
46. van Campen JS, Jansen FE, Kleinrensink NJ, Joëls M, Braun KP, Bruining H (2015) Sensory modulation disorders in childhood epilepsy. J Neurodev Disord 7:34.CrossRef Medline
47. Wan Q, Xiong ZG, Man HY, Ackerley CA, Braunton J, Lu WY, Becker LE, MacDonald JF, Wang YT (1997) Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature 388:686-690.CrossRef Medline
48. Zhang Z, Sun QQ (2011) The balance between excitation and inhibition and functional sensory processing in the somatosensory cortex. Int Rev Neurobiol 97:305-333.CrossRef Medline